Diagnosis and treatment of intravesical obstruction as a complication after TVT surgery for the treatment of stress urinary incontinence in women
DOI:
https://doi.org/10.61841/y8k3r795Keywords:
intravesical obstruction, risk factors, clinical features, sling surgery, stress urinary incontinenceAbstract
The focus of the publication is the diagnosis and treatment of intravesical obstruction - a complication after TVT surgery. The aim is to establish the complication rate. For the period 2005-2019. 436 women with TVT were operated on for treatment of stress incontinence, 45 (10.3%) of them developed IVO. In 334 women using the TVT-O-33 method, IVO was developed, in 78 operated on TVT-R, the problem was in 12 patients, and in 24 with TVT-Ophira, this complication was not detected. Early IVO at day 1 postoperatively was observed in 16 women (35.5%), at day 14 IVO had 53.3%, and late complication was observed in 5 patients (11.1%). Treatment begins with conservative methods, and in the case of non-response proceeds to surgery. I used a retrospective method to determine the complication rate within the appropriate postoperative period. The study concluded that 15.4% of IVO was detected after TVT-R, 9.8% with TVT-O and 0% with Single incision.
Downloads
References
1. Nidhi S, Sudakshina C. Clinical evaluation of urinary incontinence. J Midlife Health 2018; 9(2): 55–64.
2. Rautenberg O, Zivanovic I, Kociszewski J, Kuszka A, Münst J, Eisele L, et al. Current treatment concepts for stress urinary incontinence. Praxis (Bern 1994) 2017;106(15):829e-836e.
3. Button BM, Holland AE, Sherburn MS, Chase J,Wilson JW, BurgeAT. Prevalence, impact and specialised treatment of urinary incontinence inwomenwith chronic lung disease. Physiotherapy 2018 pii: S0031-9406(18)30155-X
4. Gibson, W. & Wagg, A. Are older women more likely to receive surgical treatment for stress urinary incontinence since the introduction of the mid-urethral sling? An examination of Hospital Episode Statistics data. B.J.O.G, 2016; 123, 1386–1392
5. Medicines and Healthcare Products Regulatory Agency, MHRA. A summary of the evidence on the benefits and risks of vaginal mesh implants,2014 https://www.gov.uk/government/publications/vaginal-mesh-implants-summary-of-benefits-and-risks
6. Glazener, C.M.A What is the role of mid-urethral slings in the management of stress incontinence in women? Cochrane Database Syst. Rev. 7, 2015 https://doi.org/10.1002/14651858.ED000101
7. Dyer, O. Johnson and Johnson faces lawsuit over vaginal mesh devices. B.M.J. 2016 353, i3045
8. U.S. Food and Drug Administration, FDA. U.S. Food and Drug Administration Executive Summary: Reclassification of Urogynecologic Surgical Mesh Instrumentation. 2016 http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/Medic alDevicesAdvisoryCommittee/Gastroenterology-UrologyDevicesPanel/UCM487224
9. Malde S, Solomon E, Spilotros M, Mukhtar B, Pakzad M, Hamid R, et al. Female bladder outlet obstruction: Common symptoms masking an uncommon cause. Low Urin Tract Symptoms 2019;11(1):72-77.
10. Lin CD, Kuo HC, Yang SS. Diagnosis and Management of Bladder Outlet Obstruction in Women. Low Urin Tract Symptoms 2016;8(1):30-7.
11. The Scottish Independent Review of the Use, Safety and Efficacy of Transvaginal Mesh Implants in the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in Women, 2015. http://www.gov.scot/Publications/2015/10/8485
12. Meier K, Padmanabhan P. Female bladder outlet obstruction: an update on diagnosis and management. Curr Opin Urol 2016 Jul;26(4):334-41.
13. Chung E., Tse V., Chan L. Mid-urethral synthetic slings in the treatment of urodynamic female stress urinary incontinence without concomitant pelvic prolapse repair: 4-year health-related quality of life outcomes. BJU Int. 2009. Vol. 105. P. 514-517.
14. Miller E.A., Webster G.D. Postoperative complications of sling surgery. Vasavada S.P., Appell R.A., Sand P.K., Raz S. (eds). Female Urology, Urogynecology, and Voiding Dysfunction. - New York: Taylor and Francis, 2005. P. 447-455.
15. Nitti V.W., Tu L.M., Gitlin J. Diagnosing bladder outlet obstruction in women. J. Urol. 1999. Vol. 161. P. 1535-1540.
16. Gamble T.L., Botros S.M., Beaumont J.L. et al. Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am. J. Obstet. Gynecol. 2008. Vol. 199. P. 696; e1-7.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
